Island Pharmaceuticals Limited (ASX:ILA)
Australia
· Delayed Price · Currency is AUD 0.420
+0.005 (1.20%)
At close: Mar 6, 2026
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 123.80 million as of March 6, 2026. Its market cap has increased by 383.66% in one year.
Market Cap
123.80M
Enterprise Value
116.93M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 123.80M, an increase of 191.24%. That is a compound annual growth rate of 24.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 123.80M | 7.01% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Botanix Pharmaceuticals | 122.00M |
| Recce Pharmaceuticals | 130.13M |
| Paradigm Biopharmaceuticals | 109.81M |
| Actinogen Medical | 143.02M |
| Starpharma Holdings | 155.37M |
| Arovella Therapeutics | 96.57M |
| Cynata Therapeutics | 81.92M |
| Tetratherix | 194.43M |